CLRO
ClearOne, Inc.
There isn't enough reported data to score CLRO yet.
SNDK
Sandisk Corporation
SNDK's fundamentals are strong: revenue more than tripled and its operating margin went from −19% to 72%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CLRO Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
CLRO's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CLRO PE Valuation
CLRO has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
CLRO Forward outlook
There aren't enough analyst estimates for CLRO to show an outlook.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
CLRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.34 | +$10.07 |
| Q2 2026 | -$11.00 | -$4.16 |
| Q1 2026 | -$13.30 | -$7.30 |
| Q4 2025 | -$14.77 | -$9.22 |
| Q3 2025 | -$13.41 | -$10.71 |
| Q2 2025 | -$6.84 | -$4.59 |
| Q1 2025 | -$6.00 | -$4.95 |
| Q4 2024 | -$5.55 | -$5.25 |
CLRO lost $3.34 per share over the past year, a smaller loss than the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CLRO in the latest year-over-year earnings comparison.
CLRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $1.9M | -17% |
| Q1 2025 | $2.3M | -36% |
| Q4 2024 | $3M | -29% |
| Q3 2024 | $2.5M | -49% |
| Q2 2024 | $2.3M | -58% |
| Q1 2024 | $3.6M | -13% |
| Q4 2023 | $4.2M | +3.3% |
| Q3 2023 | $4.9M | -22% |
CLRO's revenue has slid since its 2020 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -238% | -111 points |
| Q1 2025 | -123% | -66 points |
| Q4 2024 | -68% | -27 points |
| Q3 2024 | -87% | -57 points |
| Q2 2024 | -127% | -102 points |
| Q1 2024 | -57% | -5 points |
| Q4 2023 | -42% | +23 points |
| Q3 2023 | -30% | -12 points |
CLRO's operating margin was −238% last quarter, down 111 points from the same quarter a year ago, near the bottom of its range since 2019.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over CLRO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK's operating margin was 80% last quarter, up 72 points from the same quarter a year ago, near the top of its range since 2023.
CLRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$905K | +$224K |
| Q1 2026 | -$680K | +$776K |
| Q4 2025 | -$11.2M | -$9.7M |
| Q3 2025 | -$754K | +$1.1M |
| Q2 2025 | -$1.1M | +$2.1M |
| Q1 2025 | -$1.5M | -500% |
| Q4 2024 | -$1.6M | -145% |
| Q3 2024 | -$1.9M | -$50K |
CLRO has burned cash in most quarters: −$14M over the past year, against −$6M the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over CLRO on cash generation, producing positive trailing cash flow while its opponent burns cash.
CLRO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +54% | +942K shares |
| 3 years | +68% | +1.1M shares |
| 5 years | +114% | +1.4M shares |
| Available history | +141% | +1.6M shares |
CLRO has 3M diluted shares, up 54% from a year ago.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over CLRO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CLRO Net Leverage
CLRO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CLRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.0 | Neutral |
| Stochastic | 18.8 | Oversold |
CLRO's weekly RSI is 46 (neutral) and its Stochastic is 19 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CLRO PE vs Technology Sector
| Metric | CLRO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CLRO has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
CLRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.70 | 5.9% below |
| 20 week MA | $5.08 | 31% below |
| 50 week MA | $4.74 | 27% below |
| 100 week MA | $5.94 | 41% below |
| 200 week MA | $10.2 | 66% below |
SNDK has stronger trend alignment. CLRO is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CLRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.3 | $37.2 | +42% |
| 2021 | $37.2 | $20.0 | -46% |
| 2022 | $20.0 | $23.1 | +16% |
| 2023 | $23.1 | $16.2 | -30% |
| 2024 | $16.2 | $9.13 | -44% |
| 2025 | $9.13 | $5.33 | -42% |
| 2026 YTD | $5.33 | $3.48 | -35% |
CLRO has finished three years in a row lower, and it's down 35% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CLRO on returns for 2026, with the stronger performance.